Clinical Application of Kidney Biomarkers in Cirrhosis

Gines, 2009, Renal failure in cirrhosis, N Engl J Med, 361, 1279, 10.1056/NEJMra0809139 Rice, 2017, The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States, Curr Med Res Opin, 33, 1473, 10.1080/03007995.2017.1331211 Angeli, 2015, Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites, Gut, 64, 531, 10.1136/gutjnl-2014-308874 Bagshaw, 2008, A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients, Nephrol Dial Transplant, 23, 1203, 10.1093/ndt/gfm744 Allegretti, 2015, Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis: a prospective cohort study, Int J Nephrol, 2015, 108139, 10.1155/2015/108139 Allegretti, 2018, Prognosis of patients with cirrhosis and AKI who initiate RRT, Clin J Am Soc Nephrol, 13, 16, 10.2215/CJN.03610417 Martin-Llahi, 2011, Prognostic importance of the cause of renal failure in patients with cirrhosis, Gastroenterology, 140, 496.e494, 10.1053/j.gastro.2010.07.043 de Araujo, 2014, Akin criteria as a predictor of mortality in cirrhotic patients after spontaneous bacterial peritonitis, Ann Hepatol, 13, 390, 10.1016/S1665-2681(19)30870-1 Belcher, 2013, Association of AKI with mortality and complications in hospitalized patients with cirrhosis, Hepatology, 57, 753, 10.1002/hep.25735 Tsien, 2013, Acute kidney injury in decompensated cirrhosis, Gut, 62, 131, 10.1136/gutjnl-2011-301255 Fagundes, 2013, A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis, J Hepatol, 59, 474, 10.1016/j.jhep.2013.04.036 Kellum, 2015, Persistent acute kidney injury, Crit Care Med, 43, 1785, 10.1097/CCM.0000000000001102 Schrier, 1988, Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis, Hepatology, 8, 1151, 10.1002/hep.1840080532 Gines, 1993, Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites, Gastroenterology, 105, 229, 10.1016/0016-5085(93)90031-7 Salerno, 2007, Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis, Gut, 56, 1310 Ruiz-del-Arbol, 2005, Circulatory function and hepatorenal syndrome in cirrhosis, Hepatology, 42, 439, 10.1002/hep.20766 Caregaro, 1994, Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis, Arch Intern Med, 154, 201, 10.1001/archinte.1994.00420020117013 Francoz, 2010, Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score, Liver Transpl, 16, 1169, 10.1002/lt.22128 Allegretti, 2017, Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome, Cochrane Database Syst Rev, 6, CD005162 Israelsen, 2017, Terlipressin versus other vasoactive drugs for hepatorenal syndrome, Cochrane Database Syst Rev, 9, CD011532 Francoz, 2019, Hepatorenal syndrome, Clin J Am Soc Nephrol, 14, 774, 10.2215/CJN.12451018 Allegretti, 2016, Siglec-7 as a novel biomarker to predict mortality in decompensated cirrhosis and acute kidney injury, Dig Dis Sci, 61, 3609, 10.1007/s10620-016-4316-x Allegretti, 2019, Serum angiopoietin-2 predicts mortality and kidney outcomes in decompensated cirrhosis, Hepatology, 69, 729, 10.1002/hep.30230 Sole, 2018, Characterization of inflammatory response in hepatorenal syndrome: relationship with kidney outcome and survival, Liver Int, 39, 1246, 10.1111/liv.14037 Sole, 2016, Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis, Sci Rep, 6, 32341, 10.1038/srep32341 Wiesner, 2003, Model for end-stage liver disease (MELD) and allocation of donor livers, Gastroenterology, 124, 91, 10.1053/gast.2003.50016 Kim, 2008, Hyponatremia and mortality among patients on the liver-transplant waiting list, N Engl J Med, 359, 1018, 10.1056/NEJMoa0801209 Malinchoc, 2000, A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts, Hepatology, 31, 864, 10.1053/he.2000.5852 Alessandria, 2005, MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation, Hepatology, 41, 1282, 10.1002/hep.20687 Blantz, 1998, Pathophysiology of pre-renal azotemia, Kidney Int, 53, 512, 10.1046/j.1523-1755.2003_t01-1-00784.x Waikar, 2012, Imperfect gold standards for kidney injury biomarker evaluation, J Am Soc Nephrol, 23, 13, 10.1681/ASN.2010111124 Lafrance, 2010, Defining acute kidney injury in database studies: the effects of varying the baseline kidney function assessment period and considering CKD status, Am J Kidney Dis, 56, 651, 10.1053/j.ajkd.2010.05.011 Siew, 2012, Estimating baseline kidney function in hospitalized patients with impaired kidney function, Clin J Am Soc Nephrol, 7, 712, 10.2215/CJN.10821011 Waikar, 2009, Creatinine kinetics and the definition of acute kidney injury, J Am Soc Nephrol, 20, 672, 10.1681/ASN.2008070669 Mehan, 2013, Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics, Adv Exp Med Biol, 735, 283, 10.1007/978-1-4614-4118-2_20 Blank, 2018, Biomarkers of drug-induced acute kidney injury: a regulatory perspective, Expert Opin Drug Metab Toxicol, 14, 929, 10.1080/17425255.2018.1511701 Siew, 2011, Biological markers of acute kidney injury, J Am Soc Nephrol, 22, 810, 10.1681/ASN.2010080796 Koyner, 2012, Biomarkers predict progression of acute kidney injury after cardiac surgery, J Am Soc Nephrol, 23, 905, 10.1681/ASN.2011090907 Parikh, 2011, Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery, J Am Soc Nephrol, 22, 1748, 10.1681/ASN.2010121302 Mishra, 2005, Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery, Lancet, 365, 1231, 10.1016/S0140-6736(05)74811-X Arthur, 2014, Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery, Kidney Int, 85, 431, 10.1038/ki.2013.333 Zarbock, 2016, Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial, JAMA, 315, 2190, 10.1001/jama.2016.5828 Parikh, 2004, Urinary interleukin-18 is a marker of human acute tubular necrosis, Am J Kidney Dis, 43, 405, 10.1053/j.ajkd.2003.10.040 Parikh, 2010, Acute kidney injury: defining prerenal azotemia in clinical practice and research, Nat Rev Nephrol, 6, 641, 10.1038/nrneph.2010.128 Coca, 2014, Urinary biomarkers of AKI and mortality 3 years after cardiac surgery, J Am Soc Nephrol, 25, 1063, 10.1681/ASN.2013070742 Koyner, 2015, Tissue inhibitor metalloproteinase-2 (TIMP-2)IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI, J Am Soc Nephrol, 26, 1747, 10.1681/ASN.2014060556 Srisawat, 2011, Urinary biomarkers and renal recovery in critically ill patients with renal support, Clin J Am Soc Nephrol, 6, 1815, 10.2215/CJN.11261210 Tenstad, 1996, Renal handling of radiolabelled human cystatin C in the rat, Scand J Clin Lab Invest, 56, 409, 10.3109/00365519609088795 Kiessling, 2014, Early postoperative serum cystatin C predicts severe acute kidney injury following cardiac surgery: a post-hoc analysis of a randomized controlled trial, J Cardiothorac Surg, 9, 10, 10.1186/1749-8090-9-10 Inker, 2012, Estimating glomerular filtration rate from serum creatinine and cystatin C, N Engl J Med, 367, 20, 10.1056/NEJMoa1114248 Yong, 2017, Predictive value of serum cystatin C for acute kidney injury in adults: a meta-analysis of prospective cohort trials, Sci Rep, 7, 41012, 10.1038/srep41012 Malhotra, 2017, Biomarkers for the early detection and prognosis of acute kidney injury, Clin J Am Soc Nephrol, 12, 149, 10.2215/CJN.01300216 Mishra, 2003, Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury, J Am Soc Nephrol, 14, 2534, 10.1097/01.ASN.0000088027.54400.C6 Goetz, 2002, The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition, Mol Cell, 10, 1033, 10.1016/S1097-2765(02)00708-6 Schmidt-Ott, 2007, Dual action of neutrophil gelatinase-associated lipocalin, J Am Soc Nephrol, 18, 407, 10.1681/ASN.2006080882 Xu, 2015, Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3, Hepatology, 61, 692, 10.1002/hep.27447 Borkham-Kamphorst, 2011, Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1beta through nuclear factor-kappaB activation, Liver Int, 31, 656, 10.1111/j.1478-3231.2011.02495.x Fagundes, 2012, Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis, J Hepatol, 57, 267, 10.1016/j.jhep.2012.03.015 Wagener, 2006, Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery, Anesthesiology, 105, 485, 10.1097/00000542-200609000-00011 Wheeler, 2008, Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock, Crit Care Med, 36, 1297, 10.1097/CCM.0b013e318169245a Okamura, 1995, Cloning of a new cytokine that induces IFN-gamma production by T cells, Nature, 378, 88, 10.1038/378088a0 Wu, 2008, IL-18 contributes to renal damage after ischemia-reperfusion, J Am Soc Nephrol, 19, 2331, 10.1681/ASN.2008020170 Tsai, 2013, Acute renal failure in cirrhotic patients with severe sepsis: value of urinary interleukin-18, J Gastroenterol Hepatol, 28, 135, 10.1111/j.1440-1746.2012.07288.x Siew, 2010, Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes, Clin J Am Soc Nephrol, 5, 1497, 10.2215/CJN.09061209 Liu, 2013, Urinary interleukin 18 for detection of acute kidney injury: a meta-analysis, Am J Kidney Dis, 62, 1058, 10.1053/j.ajkd.2013.05.014 Ichimura, 1998, Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury, J Biol Chem, 273, 4135, 10.1074/jbc.273.7.4135 Han, 2002, Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury, Kidney Int, 62, 237, 10.1046/j.1523-1755.2002.00433.x Han, 2008, Urinary biomarkers in the early diagnosis of acute kidney injury, Kidney Int, 73, 863, 10.1038/sj.ki.5002715 Doi, 2010, Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury, Crit Care Med, 38, 2037, 10.1097/CCM.0b013e3181eedac0 Yamamoto, 2007, Renal L-type fatty acid--binding protein in acute ischemic injury, J Am Soc Nephrol, 18, 2894, 10.1681/ASN.2007010097 Kashani, 2013, Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury, Crit Care, 17, R25, 10.1186/cc12503 Zhang, 2019, Urinary cell cycle arrest biomarker [TIMP-2].[IGFBP7] in patients with hepatorenal syndrome, Biomarkers, 24, 692, 10.1080/1354750X.2019.1652347 Mindikoglu, 2014, Performance of Chronic Kidney Disease Epidemiology Collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis, Hepatology, 59, 1532, 10.1002/hep.26556 Wan, 2013, Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure, World J Gastroenterol, 19, 9432, 10.3748/wjg.v19.i48.9432 Molitoris, 2016, Quantifying glomerular filtration rates in acute kidney injury: a requirement for translational success, Semin Nephrol, 36, 31, 10.1016/j.semnephrol.2016.01.008 Slack, 2013, Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers, Aliment Pharmacol Ther, 37, 989, 10.1111/apt.12299 Markwardt, 2017, Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis, Hepatology, 66, 1232, 10.1002/hep.29290 2018, Electronic address eee, European Association for the Study of the L. EASL Clinical practice guidelines for the management of patients with decompensated cirrhosis, J Hepatol, 69, 406, 10.1016/j.jhep.2018.03.024 Belcher, 2014, Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury, Hepatology, 60, 622, 10.1002/hep.26980 Verna, 2012, Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis, Dig Dis Sci, 57, 2362, 10.1007/s10620-012-2180-x Huelin, 2019, Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study, Hepatology, 70, 319, 10.1002/hep.30592 Ariza, 2015, Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis, PloS One, 10, 10.1371/journal.pone.0128145 Qasem, 2014, Urinary biomarkers of acute kidney injury in patients with liver cirrhosis, ISRN Nephrol, 2014, 376795, 10.1155/2014/376795 Jaques, 2019, Biomarkers for acute kidney injury in decompensated cirrhosis: a prospective study, Nephrology (Carlton), 24, 170, 10.1111/nep.13226 Treeprasertsuk, 2015, Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions, BMC Gastroenterol, 15, 140, 10.1186/s12876-015-0372-5 Puthumana, 2017, Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 15, 1003, 10.1016/j.cgh.2016.11.035 Belcher, 2014, Urinary biomarkers and progression of AKI in patients with cirrhosis, Clin J Am Soc Nephrol, 9, 1857, 10.2215/CJN.09430913 Yap, 2017, Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis, Dig Liver Dis, 49, 202, 10.1016/j.dld.2016.11.001 Singal, 2018, Biomarkers of renal injury in cirrhosis: association with acute kidney injury and recovery after liver transplantation, Nephron, 138, 1, 10.1159/000479074 Levitsky, 2014, Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation, Hepatology, 60, 2017, 10.1002/hep.27346 Levitsky, 2019, External validation of a pretransplant biomarker model (REVERSE) predictive of renal recovery after liver transplantation, Hepatology, 70, 1349, 10.1002/hep.30667 Cullaro, 2019, Changes in simultaneous liver-kidney transplant allocation policy may impact postliver transplant outcomes, Transplantation, 103, 959, 10.1097/TP.0000000000002403 Lei, 2018, Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis, Sci Rep, 8, 7962, 10.1038/s41598-018-26226-6 Barreto, 2014, Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections, J Hepatol, 61, 35, 10.1016/j.jhep.2014.02.023 Ariza, 2016, Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis, J Hepatol, 65, 57, 10.1016/j.jhep.2016.03.002 Lu, 2018, Serum NGAL is superior to cystatin C in predicting the prognosis of acute-on-chronic liver failure, Ann Hepatol, 18, 155, 10.5604/01.3001.0012.7907 Huelin, 2017, Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure, Clin Gastroenterol Hepatol, 15, 438, 10.1016/j.cgh.2016.09.156